Retro Biosciences: Developing therapies to extend healthy human lifespan.
7+ YOE7+ years hands-on regulatory CMC experience, experience leading CMC strategy for cell therapies, IND/CTA experience, ability to prepare CMC dossiers and lead health-authority interactions; life sciences degree preferred.
ImmunEdge: Biopharmaceutical developing novel therapeutics for serious diseases.
15+ YOE15+ years of biologics CMC or technical operations experience, bispecific antibody expertise, GMP campaign accountability, external CDMO leadership, CMC regulatory filing experience, and a relevant bachelor's or advanced degree.
WuXi BiologicsHong Kong Stock Exchange: 2269: Provides discovery, development, and manufacturing services for biologic drugs.
8+ YOEAdvanced degree (PhD/MS) with 8+ years relevant biologics CMC experience, regulatory/ICH knowledge, multi‑functional CMC expertise, project and people management, English and basic Mandarin communication.
Eikon TherapeuticsNASDAQ: EIKN: Discovers drugs using advanced live-cell imaging and protein tracking.
5+ YOEDegree in analytical chemistry or related field with ~5+ years relevant analytical/CMC experience; hands-on method development, transfer, validation; knowledge of HPLC/UPLC, GC, LC-MS, KF, spectroscopy, stability and regulatory CMC expectations.
14+ YOEDirector/ Senior Director-level CMC leadership for lirentelimab; 14+ years in biotech with BLA/submission experience; cross-functional team leadership.
CMC, Regulatory, Quality, Bioanalytics, Process Development, Manufacturing
Vera TherapeuticsNASDAQ: VERA: Develops treatments for serious immunological and autoimmune diseases.
6+ YOEBA/BS in a scientific field with minimum 6 years of regulatory affairs experience; strong US regulatory knowledge; CMC development in biologics preferred; proficient in regulatory information management systems (Veeva Vault RIM a plus).
Gilead SciencesNASDAQ: GILD: Develops and sells medicines for life-threatening infectious diseases.
4+ YOEBachelor’s degree in Life Sciences, Chemistry, Pharmacy, or related discipline; 4–6+ years in pharmaceutical project, CMC development, or CMC Regulatory Affairs; Regulatory Affairs Certification a plus.
Travere TherapeuticsNASDAQ: TVTX: Developing and selling therapies for rare kidney diseases.
10+ YOE6+ MgmtPh.D. or equivalent,10+ years CMC experience in pharma/biotech,6+ years people management,deep CMC expertise across modalities,knowledge of GMP,process validation,tech transfer,ability to synthesize technical risks for leadership.
Senti BioNASDAQ: SNTI: Develops gene circuit-engineered cell and gene therapies for cancer.
10+ YOEBA/BS in a scientific field, 10+ years regulatory CMC experience in pharma/biotech, strong knowledge of biologics regulations, leadership and agency interaction experience; gene/cell therapy experience preferred.
UltragenyxNASDAQ: RARE: Developing and commercializing therapies for rare genetic diseases.
15+ YOE10+ Mgmt15+ years in regulated pharma/biotech with CMC QA experience, 10+ years leadership, bachelor’s in relevant field (advanced degree preferred), deep GMP and regulatory knowledge, inspection and supplier oversight experience.
Veeva, Microsoft Word, Microsoft Excel, Microsoft PowerPoint, Microsoft Teams, Microsoft Project
ORIC PharmaceuticalsNasdaq: ORIC: Develops oncology therapies addressing mechanisms of drug resistance.
10+ YOE10+ years pharmaceutical CMC experience, degree in technical discipline or equivalent, strong CMC regulatory writing (M2/M3), eCTD familiarity, cGMP and global regulatory knowledge, and ability to lead cross-functional teams.
Cambridge or Research Triangle Park or San Francisco
$204k-$281k/yrHybridFull Time
BiogenNASDAQ: BIIB: Develops therapies for neurological and neurodegenerative diseases.
12+ YOE12+ years' experience in matrix leadership with CMC/supply chain or life cycle management; BS required, advanced degree preferred; alliance and financial management experience; strong strategic, communication and risk-management skills.
Marea Therapeutics: Developing novel therapies for patients with cardioendocrine diseases.
15+ YOE15+ years industry experience with ≥10 years in CMC regulatory for biologics; experience with mAb development, IND/BLA/MAA filings, GMP/ICH/FDA/EMA guidance, drug-device combination products, and building regulatory teams.
Denali TherapeuticsNASDAQ: DNLI: Developing medicines for neurodegenerative and lysosomal storage diseases.
12+ YOERequires BA/BS and 12+ years of relevant biotech, pharmaceutical, or CMO CMC experience, or master's degree with 10+ years. Requires CRO/CMO management, GMP experience, and project management expertise.
Allogene TherapeuticsNASDAQ: ALLO: Develops allogeneic cell therapies for cancer and autoimmune diseases
7+ YOE3+ MgmtBachelor's in life sciences (or equivalent), 7+ years project management experience in biotech with CMC exposure, 3+ years leading cross-functional teams, PMP preferred, CMC and clinical development knowledge, proficiency with Smartsheet, Microsoft Project, SharePoint, and Office; U.S. work authorization required.
Smartsheet, Microsoft Project, Microsoft SharePoint, Microsoft Office Suite
Vir BiotechnologyNASDAQ: VIR: Developing medicines for infectious diseases and cancer.
10+ YOEAdvanced degree, 10+ years pharmaceutical CMC regulatory experience including IND/CTA and BLA/MAA submissions, knowledge of FDA/EMA/ICH guidelines, Health Authority interactions, and strong presentation skills.
IDEAYA BiosciencesNASDAQ: IDYA: Develops precision medicine oncology therapies for cancer patients.
8+ YOEPhD+8 years or MSc+12 years in process chemistry/development, experience with DS/CMC across development phases, CDMO management, strong regulatory and quality knowledge, leadership and cross-functional collaboration.
Revolution MedicinesNASDAQ: RVMD: Developing precision oncology therapies for RAS-addicted cancers
10+ YOE10+ years in pharma/biotech drug development with 5+ years global CMC regulatory; experience with IND, IMPD/CTA, NDA, MAA submissions; strong US/EU/APAC GMP regulatory knowledge.